Intent to Grant an Exclusive License for U.S. Government-Owned Invention

Name of License: Intent to Grant an Exclusive License for U.S. Government-Owned Invention

Laboratory:

On: Jul 05, 2022

Summary:

In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license.

Tech Name: Spray Polyurethane Foam Splint: FastCast(tm)

Action: Intent

Dates: July 5, 2022

Address: Commander, U.S. Army Medical Research and Development Command (USAMRDC), ATTN: Director, Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702-5012.

For Further Information Contact:

Dr. Paul Michaels, Office of Research & Technology Applications, (301) 619-4145. For patent issues, Ms. Leigh Callander, Supervisory Patent Attorney, (301) 619-7808.

Supplementary Information:

In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license to Triton Systems, Inc., having its principle place of business at 330 Billerica Road, Suite 200, Chelmsford, MA 01824. The license agreement includes following U.S. Patents and U.S. Patent Applications:
 U.S. Patent No. 9,427,489, issued on August 30, 2016, for invention titled “ Spray Foam Splint”;
 U.S. Patent No. 10,350,103, issued on July 16, 2019, for an invention titled “Spray Foam Splint”.
Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Director, Office of Research and Technology Applications

Download PDF